Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality

Archives of Internal Medicine

Volumn 161, Issue 11, 2001, Pages 1413-1419

  Cui, Yadong ^a   Blumenthal, Roger S ^b   Flaws, Jodi A ^a   Whiteman, Maura K ^a   Langenberg, Patricia ^a   Bachorik, Paul S ^c   Bush, Trudy L ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NON HIGH DENSITY LIPOPROTEIN CHOLESTEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SEX RATIO; SYSTOLIC BLOOD PRESSURE;

EID: 0034912018     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.161.11.1413     Document Type: Article

References (55)

1. Second report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
2. Cholesterol and lipids in the risk of coronary artery disease: The Framingham heart study
3. Increased risk of coronary heart disease death in men with low total and low-density lipoprotein cholesterol in the Russian Lipid Research Clinics Prevalence Follow-up Study
4. Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease
5. Prediction of coronary heart disease using risk factor categories
6. Rationale for use of non-high-density lipoprotein cholesterol rather than low-density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy
7. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
8. HDL serum cholesterol and 24-year mortality of men in Finland
9. Multivariate prediction of coronary deaths in a 10-year follow-up of an Italian occupational male cohort
10. High density lipoprotein cholesterol is not a major risk factor for ischaemic heart disease in British men
11. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women
12. Serum lipids and incidence of coronary heartisease: Findings from the Systolic Hypertension in the Elderly Program (SHEP)
13. High-density lipoprotein cholesterol and cardiovascular disease: Four prospective American studies
14. Plasma lipid distributions in selected North American populations: The Lipid Research Clinics Program Prevalence Study
15. Common methods, different populations: The Lipid Research Clinics Program Prevalence Study
16. Populations and methods for assessing dyslipoproteinemia and its correlates: The Lipid Research Clinics Program Prevalence Study
17. Lipid and lipoprotein analysis
18. Plasma triglyceride level and mortality from coronary heart disease
19. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: The follow-up study of the Lipid Research Clinics Prevalence Study
20. Management of primary hyperlipidemia
21. Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM
22. A prospective investigation of elevated lipoprotein(a) detected by electrophoresis and cardiovascular disease in women: The Framingham heart study
23. Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger: A prospective study
24. Predictive value of electrophoretically detected lipoprotein(a) for coronary heart disease and cerebrovascular disease in a community-based cohort of 9936 men and women
25. Beyond low-density lipoprotein cholesterol: A perspective on low high-density lipoprotein disorders and Lp(a) lipoprotein excess
26. Lipoprotein(a) levels and risk of coronary heart disease in men: The Lipid Research Clinics Coronary Primary Prevention Trial
27. Lipoprotein(a)-cholesterol and coronary heart disease in the Framingham heart study
28. Lipoprotein Lp(a) excess and coronary heart disease
29. A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City project participants
30. Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease
31. The association of increased levels of intermediate-density lipoproteins with smoking and with coronary artery disease
32. Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolaemic men
33. Postprandial hyperlipidemia and remnant lipoproteins
34. McCollum award lecture, 1993: Triglyceride-rich lipoproteins and atherosclerosis: New perspectives
35. Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin
36. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: A metaanalysis of population-based prospective studies
37. Plasma lipoprotein levels as predictors of cardiovascular death in women
38. Management of dyslipidemia in NIDDM
39. Atherogenic lipoprotein phenotype: A proposed genetic marker for coronary heart disease risk
40. Report of the conference on low blood cholesterol: Mortality associations
41. Serum cholesterol and 20-year mortality in black and white men and women aged 65 and older in the Evans County Heart Study
42. Cholesterol, coronary heart disease, and total mortality in middle-aged and elderly men and women in Tecumseh
43. Serum cholesterol: Doing the right thing
44. Assessing possible hazards of reducing serum cholesterol
45. Low total cholesterol is associated with high total mortality in patients with coronary heart disease: The Bezafibrate Infarction Prevention (BIP) Study Group
46. The Munster heart study (PROCAM): Total mortality in middle-aged men is increased at low total and LDL cholesterol concentrations in smokers but not in nonsmokers
47. Serum cholesterol level and mortality findings for men screened in the multiple risk factor intervention trial
48. Serum cholesterol in young men and subsequent cardiovascular disease
49. Role of smoking in the U-shaped relation of cholesterol to mortality in men: The Framingham study
50. Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality: A 21 -year follow-up of 8000 men
51. Association of high-densitylipoprotein cholesterol with mortality and other risk factors for major chronic noncommunicable diseases in samples of US and Russian men
52. Association of lipids and lipoprotein level with total mortality and mortality caused by cardiovascular and cancer diseases
53. Predictive value of the exercise tolerance test for mortality in North American men: The Lipid Research Clinics Mortality Follow-up Study
54. Frequency and clustering of nonlipid coronary risk factors in dyslipoproteinemia: The Lipid Research Clinics Program Prevalence Study